Shares of ConvaTec Group PLC (LON:CTEC - Get Free Report) hit a new 52-week low on Thursday . The stock traded as low as GBX 208.60 and last traded at GBX 211, with a volume of 7088742 shares. The stock had previously closed at GBX 211.20.
Analysts Set New Price Targets
CTEC has been the topic of several recent analyst reports. Jefferies Financial Group reiterated a "buy" rating and set a GBX 325 price objective on shares of ConvaTec Group in a report on Friday, April 10th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a GBX 315 price objective on shares of ConvaTec Group in a report on Wednesday, April 8th. Berenberg Bank reiterated a "buy" rating and set a GBX 340 price objective on shares of ConvaTec Group in a report on Tuesday, April 21st. Citigroup reiterated an "outperform" rating and set a GBX 315 price objective on shares of ConvaTec Group in a report on Thursday, March 5th. Finally, Stifel Nicolaus reaffirmed a "buy" rating and set a GBX 315 price target on shares of ConvaTec Group in a research report on Wednesday, March 11th. Nine research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of GBX 319.67.
Read Our Latest Stock Report on ConvaTec Group
ConvaTec Group Trading Down 0.1%
The business's 50-day moving average is GBX 231.31 and its two-hundred day moving average is GBX 234.39. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 106.19. The stock has a market capitalization of £4.12 billion, a PE ratio of 24.53, a PEG ratio of 0.93 and a beta of 0.84.
Insiders Place Their Bets
In related news, insider Jonny Mason sold 291,149 shares of the company's stock in a transaction on Monday, March 16th. The shares were sold at an average price of GBX 234, for a total transaction of £681,288.66. Company insiders own 0.95% of the company's stock.
ConvaTec Group Company Profile
(
Get Free Report)
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ConvaTec Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ConvaTec Group wasn't on the list.
While ConvaTec Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.